1 employees
TelomEye Pharmaceuticals provides treatments to prevent and improve age-related ophthalmologic disorders.
2021
$1M
from 1 investors over 1 rounds
TelomEYE Pharmaceutical Corporation raised $1M on November 17, 2022
Investors: Re-Pie Real Estate and Private Equity Asset Management Company